Showing 1 - 10 of 37,374
Based on interviews in LEO Pharma, UCB Pharma and Novo Nordisk, we document how deep-seated changes in the pharmaceutical industry related to increasing demands from payers, the strengthening of the role of patients, changing legal demands, and declining technological opportunity, drive a...
Persistent link: https://www.econbiz.de/10014037547
Persistent link: https://www.econbiz.de/10011811768
Persistent link: https://www.econbiz.de/10011811773
Persistent link: https://www.econbiz.de/10013482648
Persistent link: https://www.econbiz.de/10014258977
Persistent link: https://www.econbiz.de/10012879116
Persistent link: https://www.econbiz.de/10012515371
, little is known about how these capabilities may contribute to the business model's innovation of an acquirer. The purpose of … the paper is to clarify the role of dynamic capabilities in business model innovation of acquirer's company in mergers and … innovation in pursuing a new customer value proposition in the merger and acquisition processes and thereby exploiting a …
Persistent link: https://www.econbiz.de/10012029724
Purpose: The article analyzes the effects of Artificial Intelligence (AI) on Business Model Innovation (BMI), focusing …
Persistent link: https://www.econbiz.de/10012489831
Persistent link: https://www.econbiz.de/10014554123